Testing effectiveness (Phase 2)UnknownNCT02803840What this trial is testingLow-dose Radiotherapy for Diffuse Large B-cell LymphomaWho this might be right forLymphoma Centro di Riferimento Oncologico - Aviano 25
Not applicableLooking for participantsNCT06299540What this trial is testingBenefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic LeukemiaWho this might be right forLeukemia, Lymphocytic, Chronic, B-Cell Janssen Cilag S.A.S. 180
Testing effectiveness (Phase 2)Looking for participantsNCT04792489What this trial is testingDALY II USA/ MB-CART2019.1 for DLBCLWho this might be right forRefractory Diffuse Large B Cell Lymphoma (DLBCL)Relapsed Diffuse Large B Cell LymphomaHigh Grade B-cell Lymphoma (HGBCL)+6 more Miltenyi Biomedicine GmbH 315
Not applicableStudy completedNCT01266668What this trial is testingThe Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL)Who this might be right forLymphoma, Large B-Cell, Diffuse Chonbuk National University Hospital 100
Not applicableStudy completedNCT04858568What this trial is testingImmune Responses to COVID-19 Vaccination in Lymphoma PatientsWho this might be right forClassical Hodgkin LymphomaDiffuse Large B Cell LymphomaPrimary Mediastinal B Cell Lymphoma+10 more University Hospital Southampton NHS Foundation Trust 592
Not applicableUnknownNCT04237168What this trial is testingNon-invasive Tumor Immunoglobulin Gene Next Generation Sequencing (IgNGS) in Diffuse Large B Cell Lymphoma (DLBCL)Who this might be right forLymphoma, Large B-Cell, Diffuse Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 30
Not applicableEnded earlyNCT00594308What this trial is testingIn-Vivo Activated T-Cell Depletion to Prevent GVHDWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more Indiana University 10
Not applicableStudy completedNCT00213876What this trial is testingResearch of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain TumoursWho this might be right forOligodendrogliomas University Hospital, Strasbourg, France 189
Not applicableApproved For MarketingNCT05733650What this trial is testingExpanded Access Program for EpcoritamabWho this might be right forLarge B-cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPrimary Mediastinal Large B-cell Lymphoma (PMBCL)+2 more Genmab
Not applicableLooking for participantsNCT07057765What this trial is testingPredictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCLWho this might be right forDLBCL - Diffuse Large B Cell LymphomaMarkers of Inflammation Ain Shams University 40
Testing effectiveness (Phase 2)UnknownNCT02846584What this trial is testingA Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell MalignanciesWho this might be right forLymphoma, Large B-Cell, DiffuseLeukemia, Lymphocytic, Chronic, B-CellLymphoma，Malignant Southwest Hospital, China 100
Early research (Phase 1)UnknownNCT02842138What this trial is testingAutologous CD19 CAR T Cells in Relapsed or Refractory B-cell LymphomaWho this might be right forB-cell Lymphoma Peking University 25
Early research (Phase 1)Looking for participantsNCT07478848What this trial is testingRadiation, Oral Vancomycin, and CAR-T for B-Cell LymphomasWho this might be right forLarge B Cell LymphomaNon Hodgkin Lymphoma (NHL)Diffuse Large B Cell Lymphoma (DLBCL)+2 more Abramson Cancer Center at Penn Medicine 14
Early research (Phase 1)Study completedNCT00022555What this trial is testingBryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related LymphomaWho this might be right forAIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell LymphomaAIDS-related Peripheral/Systemic Lymphoma+1 more National Cancer Institute (NCI) 12
Not applicableStudy completedNCT05510908What this trial is testingUse of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMCWho this might be right forHIV-Associated Malignant NeoplasmHIV InfectionsCancer+5 more AIDS Malignancy Consortium 460
Testing effectiveness (Phase 2)Looking for participantsNCT03418038What this trial is testingAscorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic LeukemiaWho this might be right forClonal Cytopenia of Undetermined SignificanceHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRecurrent Diffuse Large B-Cell Lymphoma+5 more Mayo Clinic 80
Early research (Phase 1)Not Yet RecruitingNCT07664735What this trial is testingEvaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.Who this might be right forEndometrial Cancer RecurrentEndometrial CancerAdvanced Endometrial Cancer+4 more Outpace Bio, Inc. 30
Testing effectiveness (Phase 2)UnknownNCT00333008What this trial is testingA Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.Who this might be right forDiffuse Large B Cell LymphomaLymphoma, Non-Hodgkin The Alvin and Lois Lapidus Cancer Institute 27
Not applicableUnknownNCT05840289What this trial is testingA Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-LymphomaWho this might be right forAggressive B-Cell Non-Hodgkin Lymphoma University Hospital, Geneva 94
Not applicableLooking for participantsNCT05326308What this trial is testingZanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular LymphomaWho this might be right forWaldenström's MacroglobulinemiaChronic Lymphocytic LeukemiaMarginal Zone Lymphoma+1 more iOMEDICO AG 845